Seòmar agus comataidhean

We have established a process for individuals who have received one of their first coronavirus vaccinations outwith Scotland which allows them to upload official proof of vaccination from that country to their Scottish Vaccination record through NHS Inform . This will allow those individuals to receive a combined fully vaccinated status to show for international travel and domestic purposes.

Individuals who have been vaccinated in England or Wales can provide confirmation that they are fully vaccinated through NHS COVID Pass for domestic purposes.

The requested information on how many people were diagnosed with multiple sclerosis (MS), broken down by NHS board is not held centrally.

The Scottish Multiple Sclerosis Register provides information on new diagnoses of MS. The latest publication of the register shows 450 new patients with a confirmed diagnosis of MS were added to the MS Register in 2020.

I can confirm that the project remains on budget. There is no change to the estimated total project cost of £49.5m at Q4 2018 prices, of which the construction contract value is £18m, as reported in the Infrastructure Investment Plan updates.

Construction cost updates for the project are published on the Scottish Government website every 6 months via the Major Capital Projects update.

Data published by Public Health Scotland covering the period 01 January 2020 to 30 September 2021 shows that in NHS Grampian 83.7 % eligible referrals started treatment within the 62 day standard in 2020 and 78.2% in 2021. Representing 1081 of 1,291 referrals in 2020 and 815 of 1,042 referrals in 2021.

Further breakdown of this data can be accessed at Cancer waiting times - 1 July to 30 September 2021 - Cancer waiting times - Publications - Public Health Scotland .

Boards are continuing to prioritise new cancer patients being referred with a suspicion of cancer - this is closely monitored through weekly performance meetings with officials and reflected in Boards’ Remobilisation Plans.

A refresh of the Framework for Effective Cancer Management is underway and will support clinicians and NHS managers to drive improvements in cancer pathways, providing Health Boards with the tools to effectively manage cancer patients and ultimately recover waiting times.

£10 million of funding has been directed to support cancer waiting times improvements in NHS Scotland across 2021-22, including up-skilling nurses and investing in diagnostic tests to extended working days and weekend working, to increase capacity and see/treat cancer patients as timely as possible. NHS Grampian received £974,000 as a share of the funding.

Prioritisation within the Scottish Government’s COVID-19 vaccination programme is based upon the clinical risk of developing severe disease with COVID-19. The Joint Committee on Vaccination and Immunisation (JCVI) advises on clinical prioritisation for vaccination. Priority groups 1-9 incorporate the highest clinical risk groups and each group cohort is invited to receive vaccination accordingly.

As per guidance outlined within the Green Book, Chapter 14a, children and young people aged 12-15 years with poorly controlled asthma that requires continuous or repeated use of systemic steroids or with previous exacerbations requiring hospital admission, are included as a high risk group within chronic respiratory disease.

For full details please see p19-23: COVID-19: the green book, chapter 14a - GOV.UK (www.gov.uk) .

The following formal flood protection schemes are complete.

The Scottish Government understands the impact that COVID-19 has had on the tourism sector which is why we have supported the tourism and hospitality sector through the pandemic, not least through an extension of 100% NDR relief for all retail leisure and hospitality premises for 2021-22.

Our proposals to licence short-term lets were developed in response to concerns raised by residents and communities across Scotland and members of all parties. It is right that we are taking action now to address these concerns. We do not consider our licensing scheme to be onerous.

We have committed to working with local authorities to review levels of short-term let activity in hotspot areas in summer 2023. This review will also seek to confirm that the wider sector is still healthy, making sure we have avoided unintended consequences.

The Scottish Government published our Heart Disease Action Plan in March 2021. This sets out a number of actions to enable us to achieve our vision of minimising preventable heart disease and ensuring equitable and timely access to diagnosis, treatment and care for people with heart disease. It is relevant to a number of the recommendations of the CPG inquiry report.

Within Priority 1 of the Action Plan, there is a focus on improving the detection, diagnosis and management of risk factor conditions, including atrial fibrillation. Work is underway to deliver the commitments outlined.

In particular, the Scottish Primary Care Information Resource (SPIRE) is developing reporting on atrial fibrillation. This will allow GP practices to monitor patients on particular medications and make sure they are getting the right follow-up care.

The Action Plan also makes commitments to addressing the challenges facing the cardiac physiology workforce. Work is progressing on this. Furthermore, we are progressing commitments in the Integrated Health and Social Care Workforce Plan (2019) for Scotland to promote recruitment of cardiac physiologists over the next 3-5 years into Scientist Training Programmes and Practitioner BSC Programmes.

The CPG inquiry report also identifies the importance of improving access to data to drive improvement. In April 2021 we commissioned Public Health Scotland to develop the Scottish Cardiac Audit Programme. Extensive clinical and patient engagement is currently underway to develop the audit. Two key work streams within that engagement are atrial fibrillation and cardiac devices.

Healthcare Improvement Scotland (HIS) Scottish Intercollegiate Guideline Network (SIGN) have confirmed that they currently have no plans to update SIGN Guideline 122 - Prevention and management of venous thromboembolism.

However, on Wednesday 15 December, SIGN published a new rapid guideline: SIGN 163 - Prevention and management of venous thromboembolism (VTE) in patients with COVID-19.

We do not hold the requested information, however, information on the number of Lateral Flow Tests used and reported in Scotland is published weekly by Public Health Scotland .